MRI Sequences — T1, T2, FLAIR, DWI, SWI, Post-Contrast
This page walks through each routine MRI sequence — what it is sensitive to, classic patterns, and the traps that catch even experienced readers. Pair this with the Physics Primer page for signal-intensity rules; here, the focus is sequence-by-sequence interpretation.
🔹 Bottom Line: Sequence-by-Sequence Workflow
- T1 — anatomy + atrophy + subacute hemorrhage (bright methemoglobin) + fat + melanin. Best gray-white differentiation.
- T2 — pathology screen. Water (edema, gliosis, cyst, demyelination, infarct) bright.
- FLAIR — T2 with CSF suppressed. Workhorse for periventricular, cortical, juxtacortical lesions.
- DWI + ADC — cytotoxic edema (acute infarct, abscess, lymphoma, prion). Always pair DWI with ADC to avoid T2 shine-through.
- SWI / GRE — blood, calcium, iron, air, melanin. Detects microbleeds, cavernoma, CVT, CAA.
- Post-contrast T1 — BBB breakdown OR vascular. Pattern (ring, nodular, gyriform, leptomeningeal, dural) drives differential.
- MRA / MRV — vessels (separate page on angiography).
- Optional: post-contrast FLAIR (leptomeningeal), DTI (tractography), perfusion (CTP / DSC / ASL), MR spectroscopy.
T1-Weighted
Use
- Anatomy + atrophy assessment.
- Identifies fat, methemoglobin, melanin, mineralization, gyriform cortical laminar necrosis.
- Post-contrast T1 detects BBB breakdown / vascular structures.
What to Look For
- Cortical thickness and atrophy patterns — symmetric vs asymmetric, lobar predominance.
- Hippocampal volume — coronal MTL, especially in dementia and epilepsy workup.
- Brainstem volume — midbrain atrophy in PSP; pons + middle cerebellar peduncle atrophy in MSA.
- Bright T1 signal — subacute hemorrhage, melanin (primary melanoma, neurocutaneous melanosis), fat (lipoma, dermoid, marrow), high-protein cysts (colloid, Rathke), manganese (PN, liver failure), gadolinium deposition (dentate, globus pallidus — cumulative dosing).
- Dark T1 cortical band — laminar necrosis (subacute infarct, hypoxia, status epilepticus).
T2-Weighted
Use
- Pathology screen — most lesions are bright on T2.
- Identifies edema, gliosis, cyst, demyelination, tumor, infarct.
- Detects iron, calcium, fibrous/cellular tissue (dark).
What to Look For
- White matter T2 hyperintensity — small vessel ischemia, MS, leukodystrophy, CADASIL (anterior temporal + external capsule), Susac (corpus callosum “snowballs”).
- Deep gray T2 hyperintensity — symmetric: metabolic / toxic / mitochondrial / Wernicke / hypoxic; asymmetric: stroke, encephalitis.
- Cortical T2 hyperintensity — subacute infarct, encephalitis (HSV → medial temporal), autoimmune (limbic), CJD ribbon, status epilepticus.
- Brainstem T2 hyperintensity — pontine perforator infarcts (lacunar pattern), MS, central pontine myelinolysis, NMO, mitochondrial.
- Iron-related T2 darkening — globus pallidus (normal aging, NBIA), substantia nigra (loss of swallow-tail in PD), dentate (CTX), red nucleus.
FLAIR
Use
- T2 with CSF nulled. Sensitive to lesions next to CSF spaces — periventricular and juxtacortical.
- The single most useful sequence for MS, gliosis, low-grade tumor, encephalitis.
Patterns
- Periventricular FLAIR hyperintensity — MS plaques (perpendicular Dawson fingers), small vessel ischemia (more confluent), transependymal CSF flow (smooth halo), CADASIL.
- Juxtacortical FLAIR hyperintensity — MS (especially U-fibers), encephalitis, FCD type IIB (transmantle sign), low-grade glioma.
- Cortical FLAIR hyperintensity — subacute stroke, encephalitis, CJD ribbon, status epilepticus, MELAS stroke-like episode.
- Bilateral mesial temporal FLAIR hyperintensity — herpes encephalitis (asymmetric typically), autoimmune limbic encephalitis (anti-LGI1, anti-CASPR2, anti-Hu), seizure-related, hypoglycemia.
- Sulcal FLAIR hyperintensity — leptomeningeal disease (carcinomatous, infectious meningitis), SAH (hyperacute), hyperoxygenation under anesthesia, propofol, gadolinium leakage in renal failure.
- Splenium of corpus callosum FLAIR hyperintensity — MERS (mild encephalopathy with reversible splenial lesion), CADASIL, AED toxicity, status, MS, ischemia.
FLAIR Pitfalls
- CSF flow artifact in posterior fossa (4th ventricle) — false bright.
- Hyperoxygenation (general anesthesia, high FiO2) → diffuse sulcal FLAIR bright.
- Propofol → sulcal FLAIR brightness.
- Gadolinium leakage into CSF in renal failure or BBB-disrupted states.
DWI / ADC
Use
- Detects water motion restriction.
- True restriction = bright on DWI AND dark on ADC.
- Single most useful sequence for acute ischemic stroke (positive within minutes).
Causes of True Restriction
- Acute ischemic stroke — within minutes; “DWI-positive but FLAIR-negative” identifies treatable window.
- Abscess — central pus restricts; helps distinguish from ring-enhancing tumor.
- Hypercellular tumors — lymphoma, medulloblastoma, glioblastoma (focal areas).
- Prion disease — cortical ribbon + basal ganglia + pulvinar pattern.
- Acute MS / NMO plaque center — transient restriction.
- Herpes encephalitis — medial temporal.
- Wernicke encephalopathy — mammillary bodies, periaqueductal, dorsomedial thalamus.
- Status epilepticus — peri-ictal cortical + ipsilateral thalamus.
- Hypoglycemia — cortical (especially parieto-occipital), hippocampal, splenium.
- Epidermoid cyst — viscous fluid (distinguishes from arachnoid cyst).
- Cytotoxic lesion of corpus callosum — splenium central restriction (MERS, drug-related).
- PRES variant with infarction — late-stage cytotoxic injury.
DWI Traps
- T2 shine-through: high DWI without ADC darkness ≠ restriction. Always confirm ADC.
- T2 black-out: very dark T2 lesions (chronic blood, calcium) can appear “restricted” via inverse artifact. Correlate with SWI/T2*.
- Susceptibility artifact at skull base + posterior fossa (sinus air, dental hardware) obscures DWI — be cautious calling restriction here.
SWI / GRE / T2*
Use
- Susceptibility-weighted; sensitive to anything that distorts the local magnetic field.
- Detects blood, calcium, iron, air, melanin.
- SWI > GRE > T2* in sensitivity.
Key Findings
- Microbleeds — small (<10 mm), round, blooming hypointensities. Patterns:
- Lobar (cortical / subcortical) → cerebral amyloid angiopathy (CAA).
- Deep (basal ganglia, thalamus, pons, cerebellum) → hypertensive vasculopathy.
- Diffuse small + skull base → diffuse axonal injury.
- Mixed deep + lobar → mixed CAA / hypertensive.
- Cerebral amyloid angiopathy (modified Boston criteria) — multiple lobar microbleeds + cortical superficial siderosis ± lobar ICH in elderly. SWI is critical.
- Cavernous malformation — “popcorn” mixed-signal core + complete dark hemosiderin rim. Often multifocal in familial forms.
- Cerebral venous sinus thrombosis — low signal in occluded sinus + blooming around. Cortical vein thrombosis shows linear dark signal in superficial cortex with adjacent edema.
- Hemorrhagic transformation of infarct — petechial → confluent hyperdensity / blooming.
- Substantia nigra “swallow-tail sign” — normally bright dorsolateral SN compartment; loss = PD or atypical parkinsonism.
- MS — central vein sign — small vein passing through plaque (high specificity for MS vs ischemic white matter disease).
- Calcification — common in normal globus pallidus, choroid plexus, pineal, falx; pathologic in oligodendroglioma, meningioma, Fahr, hypoparathyroidism.
Post-Contrast T1
Use
- Detects BBB breakdown (tumors, abscess, inflammation, demyelination, metastasis).
- Highlights normal vascular structures (vessels, sinuses, choroid, pituitary stalk).
Patterns and Differential
| Pattern | Common Differential |
|---|---|
| Solid / nodular | Metastasis, lymphoma, meningioma, schwannoma, hemangioblastoma |
| Ring | Glioblastoma, metastasis, abscess (DWI + ADC distinguishes), tumefactive demyelination (open ring), radiation necrosis, lymphoma (often solid), resolving hematoma |
| Open ring (incomplete on cortical / venous side) | Tumefactive demyelinating plaque (MS) |
| Gyriform cortical | Subacute infarct (laminar necrosis, 1–2 weeks), encephalitis (HSV, autoimmune), status epilepticus, MELAS stroke-like episode |
| Leptomeningeal (sulcal / pial) | Carcinomatous meningitis (lymphoma, breast, lung, melanoma), infectious meningitis (TB, fungal, bacterial), neurosarcoidosis, IgG4 disease |
| Dural (smooth, diffuse, linear) | Intracranial hypotension, postoperative, meningioma (en plaque) |
| Dural (nodular, focal) | Meningioma, dural metastasis, neurosarcoidosis, lymphoma, Erdheim-Chester |
| Ependymal | Ependymitis (CMV in HIV/transplant), lymphoma, glioblastoma seeding, neurocysticercosis |
| Perivascular (Virchow-Robin) enhancement | Neurosarcoidosis, CNS vasculitis, lymphoma |
| Cranial nerve enhancement | Schwannoma, perineural tumor spread (head/neck cancer), neurosarcoidosis, Bell palsy (CN VII), GBS / CIDP (cauda) |
| Pituitary / sellar enhancement | Adenoma (often hypo-enhancing relative to gland), hypophysitis (homogeneous + thickened stalk), Rathke cleft, craniopharyngioma |
| Punctate “starry sky” | Miliary TB, miliary metastases, neurocysticercosis |
Post-Contrast FLAIR
- Most sensitive sequence for leptomeningeal disease — combines T2 / FLAIR contrast with gadolinium enhancement of pial vessels.
- Sensitive for early infarct cortical enhancement, low-volume hydrocephalus, low-volume SAH.
- Order when carcinomatous or infectious meningitis is suspected.
Specialty Sequences (Briefly)
- DTI / tractography: white matter tract integrity (presurgical planning, TBI, MS, leukodystrophy research).
- MR spectroscopy: metabolic profile of a voxel (NAA, choline, creatine, lipid, lactate). Useful for tumor grade, radiation necrosis vs recurrence, mitochondrial disease, NAA deficits in white matter disease.
- Functional MRI (fMRI): BOLD signal mapping for language, motor, memory; presurgical planning.
- MR perfusion (DSC, ASL): see Perfusion page.
- SVS spectroscopy mnemonic: NAA down (neuronal loss), choline up (cell turnover), lactate up (anaerobic), lipid up (necrosis).
- Time-of-flight MRA / MRV: see Angiography page.
🔹 Clinical Relevance: Building the MRI Around the Question
The right MRI protocol depends on what you’re asking:
- Acute stroke: T2, FLAIR, DWI/ADC, SWI, MRA head + neck.
- MS / demyelinating: 3D-FLAIR, T1 pre + post, T2, DWI, SWI (central vein sign), sagittal cord T2 + STIR.
- Tumor: T1 pre + post, T2, FLAIR, DWI/ADC, SWI, perfusion (DSC), spectroscopy.
- Epilepsy presurgical: high-resolution 3T, dedicated epilepsy protocol (T2, FLAIR, MPRAGE, DTI), thin-slice coronal hippocampal.
- Dementia: T1 MPRAGE volumetric, T2, FLAIR, SWI (microbleeds, CAA), targeted PET as next step.
- Encephalitis: T2, FLAIR, DWI, post-contrast T1 + post-contrast FLAIR.
- Pituitary / sellar: dynamic post-contrast T1 + sagittal + coronal thin cuts of sella.
- CSF leak / intracranial hypotension: post-contrast T1 + heavily T2-weighted MR myelography.
- NPH: T1 volumetric for DESH pattern + Evans index + callosal angle.
Pitfalls and Pearls
- Always pair DWI with ADC — T2 shine-through is the universal trap.
- Open-ring enhancement = tumefactive demyelination, not abscess or tumor.
- Central vein sign on SWI = high specificity for MS over ischemic white matter lesions.
- Mesial temporal asymmetry on FLAIR + DWI = think HSV (asymmetric, hemorrhagic, often unilateral); autoimmune limbic encephalitis (more bilateral, less aggressive); seizure-related (correlate with EEG).
- Cortical ribbon DWI + pulvinar FLAIR = CJD.
- Pulvinar T2 bright bilaterally = consider variant CJD, Fabry, hypoglycemic injury, mitochondrial.
- Splenium central focal lesion with restriction = MERS, AED-related, ischemic, MS.
- Bilateral basal ganglia symmetric T2 bright = metabolic (hypoxia, CO, methanol), Wernicke, mitochondrial (Leigh), Wilson, NPC, manganese.
- Loss of swallow-tail sign on SWI = Parkinson disease (dopaminergic SN loss).
- Smooth dural enhancement + brain sagging = intracranial hypotension; look for CSF leak.
- Gadolinium leakage into CSF in renal failure can mimic SAH on FLAIR — clinical correlation.
- Don’t read “brain MRI” without checking the cord — sagittal T1/T2 visible through cervicomedullary level.
References
- Filippi M, Preziosa P, Banwell BL, et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain. 2019;142(7):1858-1875.
- Osborn AG. Osborn’s Brain. 2nd ed. Elsevier; 2018.
- Provenzale JM. The role of advanced MR techniques in the diagnosis of brain tumors. Magn Reson Imaging Clin N Am. 2007;15(2):283-298.
- Vernooij MW, van der Lugt A, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology. 2008;70(14):1208-1214.